IND News - Candlesense

Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Company Initiates Combination Trial and Strengthens Balance Sheet to Support Continued Clinical Progress Company Initiates Combination Trial and Strengthens Balance Sheet to Support Continued Clin...

Are there any dilution concerns from potential equity raises to fund the trial? What is the anticipated impact on the company's valuation multiples relative to industry benchmarks? How might the market react to the sentiment score of 65 in the context of recent earnings trends?

Earnings

28 days ago